BRPI0807903A2 - Composições medicinais melhoradas compreendendo buprenorfina e nalmefeno. - Google Patents

Composições medicinais melhoradas compreendendo buprenorfina e nalmefeno.

Info

Publication number: BRPI0807903A2
Authority: BR; Brazil
Prior art keywords: nalmephen; buprenorphine; improved medical; medical compositions; compositions understanding
Prior art date: 2007-03-01

Application number

BRPI0807903-0A2A

Other languages

English (en)

Inventor

Christopher Bourne Chapleo

Neil Hyde

Original Assignee

Christopher Bourne Chapleo

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-03-01

Filing date

2008-02-15

Publication date

2014-06-17

2008-02-15 Application filed by Christopher Bourne Chapleo filed Critical Christopher Bourne Chapleo

2014-06-17 Publication of BRPI0807903A2 publication Critical patent/BRPI0807903A2/pt

Links

RMRJXGBAOAMLHD-IHFGGWKQSA-N buprenorphine Chemical compound C([C@]12[C@H]3OC=4C(O)=CC=C(C2=4)C[C@@H]2[C@]11CC[C@]3([C@H](C1)[C@](C)(O)C(C)(C)C)OC)CN2CC1CC1 RMRJXGBAOAMLHD-IHFGGWKQSA-N 0.000 title 1
229960001736 buprenorphine Drugs 0.000 title 1
239000000203 mixture Substances 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Epidemiology (AREA)
Emergency Medicine (AREA)
General Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Addiction (AREA)
Biomedical Technology (AREA)
Psychiatry (AREA)
Pain & Pain Management (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

BRPI0807903-0A2A 2007-03-01 2008-02-15 Composições medicinais melhoradas compreendendo buprenorfina e nalmefeno. BRPI0807903A2 (pt)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GB0703933A GB2447013A (en)	2007-03-01	2007-03-01	Analgesic composition containing buprenorphone and nalmefene
PCT/GB2008/000522 WO2008104736A1 (en)	2007-03-01	2008-02-15	Improved medicinal compositions comprising buprenorphine and nalmefene

Publications (1)

Publication Number	Publication Date
BRPI0807903A2 true BRPI0807903A2 (pt)	2014-06-17

Family

ID=37965707

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BRPI0807903-0A2A BRPI0807903A2 (pt)	2007-03-01	2008-02-15	Composições medicinais melhoradas compreendendo buprenorfina e nalmefeno.

Country Status (22)

Country	Link
US (1)	US8497280B2 (pt)
EP (1)	EP2114452B1 (pt)
JP (1)	JP5577102B2 (pt)
KR (1)	KR101437461B1 (pt)
CN (1)	CN101622012B (pt)
AR (1)	AR065582A1 (pt)
AU (1)	AU2008220572B2 (pt)
BR (1)	BRPI0807903A2 (pt)
CA (1)	CA2678568C (pt)
CL (1)	CL2008000607A1 (pt)
DK (1)	DK2114452T3 (pt)
ES (1)	ES2476865T3 (pt)
GB (1)	GB2447013A (pt)
HK (1)	HK1139868A1 (pt)
HR (1)	HRP20140591T1 (pt)
MX (1)	MX2009009134A (pt)
PE (2)	PE20120956A1 (pt)
PL (1)	PL2114452T3 (pt)
PT (1)	PT2114452E (pt)
TW (1)	TWI468163B (pt)
WO (1)	WO2008104736A1 (pt)
ZA (1)	ZA200905692B (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
UA102128C2 (en)	2008-12-05	2013-06-10	Х. Луннбек А/С	Nalmefene hydrochloride dihydrate
MX2011012502A (es) *	2009-05-25	2011-12-12	Lundbeck & Co As H	Metodo para la preparacion de hidrocloruro de nalmefeno.
EP2844236B1 (en)	2012-04-17	2018-12-19	Purdue Pharma LP	Systems and methods for treating an opioid-induced adverse pharmacodynamic response
CN103637983B (zh) *	2013-12-16	2017-08-04	科贝源(北京)生物医药科技有限公司	一种含有盐酸纳美芬的药物组合物及其制备方法
US9849124B2 (en)	2014-10-17	2017-12-26	Purdue Pharma L.P.	Systems and methods for treating an opioid-induced adverse pharmacodynamic response
CN104922061B (zh) *	2015-05-26	2017-09-22	成都天台山制药有限公司	盐酸纳美芬注射液药物组合物和制法
CA3091443A1 (en) *	2018-02-22	2019-08-29	Avior, Inc.	Transmucosal film composition and methods of making and using the same

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB8728294D0 (en) *	1987-12-03	1988-01-06	Reckitt & Colmann Prod Ltd	Treatment compositions
US5149538A (en) *	1991-06-14	1992-09-22	Warner-Lambert Company	Misuse-resistive transdermal opioid dosage form
US5272149A (en) *	1992-05-05	1993-12-21	Stalling Reginald W	Symptom controlled receptor substitution for addiction withdrawl
US6096756A (en) *	1992-09-21	2000-08-01	Albert Einstein College Of Medicine Of Yeshiva University	Method of simultaneously enhancing analgesic potency and attenuating dependence liability caused by morphine and other bimodally-acting opioid agonists
TR200001828T2 (tr) *	1997-12-22	2000-11-21	Euro-Celtique, S.A.	Opioid dozaj şekillerinin kötüye kullanımını önlemeye yönelik bir yöntem.
AR031682A1 (es) *	1999-11-19	2003-10-01	Reckitt Benckiser Helthcare Uk	Composiciones farmaceuticas
US20050191340A1 (en) *	2002-08-09	2005-09-01	Gruenenthal Gmbh	Opioid-receptor antagonists in transdermal systems having buprenorphine
US9539303B2 (en) *	2006-04-24	2017-01-10	Celgene Corporation	Treatment of Ras-expressing tumors
WO2007146730A2 (en) *	2006-06-08	2007-12-21	Gloucester Pharmaceuticals	Deacetylase inhibitor therapy
WO2008088331A1 (en) *	2007-01-19	2008-07-24	Gloucester Pharmaceuticals	Methods for increasing levels of human fetal hemoglobin

2007
- 2007-03-01 GB GB0703933A patent/GB2447013A/en not_active Withdrawn
2008
- 2008-02-15 KR KR1020097018310A patent/KR101437461B1/ko active IP Right Grant
- 2008-02-15 CN CN2008800067678A patent/CN101622012B/zh not_active Expired - Fee Related
- 2008-02-15 JP JP2009551254A patent/JP5577102B2/ja not_active Expired - Fee Related
- 2008-02-15 AU AU2008220572A patent/AU2008220572B2/en not_active Ceased
- 2008-02-15 ES ES08709413.2T patent/ES2476865T3/es active Active
- 2008-02-15 PL PL08709413T patent/PL2114452T3/pl unknown
- 2008-02-15 EP EP08709413.2A patent/EP2114452B1/en not_active Not-in-force
- 2008-02-15 CA CA2678568A patent/CA2678568C/en not_active Expired - Fee Related
- 2008-02-15 BR BRPI0807903-0A2A patent/BRPI0807903A2/pt not_active IP Right Cessation
- 2008-02-15 WO PCT/GB2008/000522 patent/WO2008104736A1/en active Application Filing
- 2008-02-15 US US12/529,314 patent/US8497280B2/en not_active Expired - Fee Related
- 2008-02-15 MX MX2009009134A patent/MX2009009134A/es active IP Right Grant
- 2008-02-15 DK DK08709413.2T patent/DK2114452T3/da active
- 2008-02-15 PT PT87094132T patent/PT2114452E/pt unknown
- 2008-02-27 TW TW97106776A patent/TWI468163B/zh not_active IP Right Cessation
- 2008-02-28 CL CL200800607A patent/CL2008000607A1/es unknown
- 2008-02-29 PE PE2012000471A patent/PE20120956A1/es not_active Application Discontinuation
- 2008-02-29 AR ARP080100883A patent/AR065582A1/es unknown
- 2008-02-29 PE PE2008000411A patent/PE20090625A1/es not_active Application Discontinuation
2009
- 2009-08-17 ZA ZA200905692A patent/ZA200905692B/xx unknown
2010
- 2010-07-06 HK HK10106539.3A patent/HK1139868A1/xx not_active IP Right Cessation
2014
- 2014-06-24 HR HRP20140591AT patent/HRP20140591T1/hr unknown

Also Published As

Publication number	Publication date
HK1139868A1 (en)	2010-09-30
CA2678568C (en)	2015-06-16
US8497280B2 (en)	2013-07-30
PE20120956A1 (es)	2012-08-01
CN101622012A (zh)	2010-01-06
US20100152222A1 (en)	2010-06-17
AU2008220572B2 (en)	2014-03-27
EP2114452A1 (en)	2009-11-11
PT2114452E (pt)	2014-07-15
AU2008220572A1 (en)	2008-09-04
GB2447013A (en)	2008-09-03
AR065582A1 (es)	2009-06-17
TW200900067A (en)	2009-01-01
PL2114452T3 (pl)	2014-09-30
JP5577102B2 (ja)	2014-08-20
GB0703933D0 (en)	2007-04-11
JP2010520184A (ja)	2010-06-10
MX2009009134A (es)	2009-09-03
WO2008104736A1 (en)	2008-09-04
EP2114452B1 (en)	2014-04-09
HRP20140591T1 (hr)	2014-09-12
CA2678568A1 (en)	2008-09-04
CL2008000607A1 (es)	2008-10-03
CN101622012B (zh)	2012-05-30
TWI468163B (zh)	2015-01-11
KR20090115862A (ko)	2009-11-09
DK2114452T3 (da)	2014-06-30
KR101437461B1 (ko)	2014-09-05
PE20090625A1 (es)	2009-06-04
ES2476865T3 (es)	2014-07-15
ZA200905692B (en)	2010-10-27

Legal Events

Date	Code	Title	Description
2014-09-30	B15G	Petition not considered as such [chapter 15.7 patent gazette]	Free format text: A PETICAO DE NO 20130004679, APRESENTADA EM 17/01/2013, EM VIRTUDE DO DISPOSTO NOS ARTS. 218 OU 219 DA LPI (LEI 9279 / 96) DE 14/05/1996, E CONSIDERADA COMO PETICAO NAO CONHECIDA POR AUSENCIA DE FUNDAMENTACAO LEGAL, UMA VEZ QUE O CEDENTE DO DOCUMENTO DE CESSAO NAO E TITULAR DO DEPOSITO.
2014-11-25	B151	Others concerning applications: resolution cancelled [chapter 15.31 patent gazette]	Free format text: ANULADA A PUBLICACAO DO DESPACHO 15.7, PUBLICADO NA RPI 2282, DE 30/09/2014, VISTO QUE A HOUVE RETIFICACAO DO DESPACHO 1.3 NA RPI NO 2289, DE 18/11/2014.
2014-12-09	B25A	Requested transfer of rights approved	Owner name: RB PHARMACEUTICALS LIMITED (GB)
2017-12-12	B08F	Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]	Free format text: REFERENTE A 10A ANUIDADE.
2018-04-03	B08K	Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Publication	Publication Date	Title
BRPI0807902A2 (pt)	2014-06-17	Composições medicinais aperfeiçoadas compreendendo buprenorfina e naltrexona.
BRPI0918652A2 (pt)	2015-08-25	Composições farmacêuticas e métodos de libração relacionadas.
BRPI0807908A2 (pt)	2014-06-17	Melhoramentos em composições medicinais.
BRPI0906962A2 (pt)	2015-07-14	Composto, e, composição farmacêutica
BRPI0906556A2 (pt)	2015-07-07	Composto, e, composição farmacêutica
BRPI0812562A2 (pt)	2019-09-24	composições terapêuticas anti-cd20 e métodos
BRPI0807905A2 (pt)	2014-06-17	Composições medicinais aperfeiçoadas compreendendo buprenorfina e naloxona.
BRPI1010768A2 (pt)	2016-11-01	composto, e, composição farmacêutica.
BRPI0813775A2 (pt)	2015-01-06	Composição
ATE528048T1 (de)	2011-10-15	Schweisshemmende/desodorierende zusammensetzung
BRPI0809573A8 (pt)	2016-10-11	composição, e, método
BRPI0814188A2 (pt)	2014-10-14	Formulações
BRPI0812592A2 (pt)	2014-11-18	Composição assada
BRPI0810557A2 (pt)	2016-07-19	composição
BRPI0917681A2 (pt)	2015-08-04	Composto, e, composição farmacêutica
DK2254873T3 (da)	2014-06-30	Benzodiazepinforbindelse og farmaceutisk sammensætning.
BRPI0811274A2 (pt)	2014-10-07	Composição
BRPI0814167A2 (pt)	2015-01-20	Composição, e, método
BR112012000831A2 (pt)	2019-09-24	compostos, composições farmacêuticas e métodos relacionados
BRPI0813692A2 (pt)	2015-01-06	Composição pesticida
DK2173831T3 (da)	2012-09-17	Brøndbehandling
BRPI0814748A2 (pt)	2015-03-03	Compostos de alditóis substituídos, composições e métodos
BRPI1011460A2 (pt)	2015-08-25	Composição desinfetante.
BRPI0812932A2 (pt)	2014-12-09	Composições e métodos de tratar câncer
BRPI0811002A2 (pt)	2015-01-27	Composição biofertilizante